Kidney disease complicates supplement use since the kidneys excrete many compounds
Research shows that individuals with obesity who received a weekly 2.4 mg dose of semaglutide, combined with a healthy lifestyle, achieved significant weight loss [1]
Glucagon-like peptide-1 receptor agonists are similar to the GLP-1 hormone, which is secreted in the gastrointestinal tract in response to eating
And, you know, this is someone who, you know, the classic doctor, even a good functional medicine provider, like you, you would have done a good thyroid workup on them
Frequency is set by your clinician after review commonly weekly or monthly
The choice between semaglutide and tirzepatide depends on factors like efficacy preferences, side effect profiles , insurance coverage, and provider recommendation rather than BMI differences